Assessment of the sedative effects of buprenorphine administered with 20 microg/kg detomidine in horses.

This research aimed to understand the sedative effects in horses when buprenorphine is administered with 20 microg/kg detomidine, performing four different treatments in a randomised, observer-blinded, crossover study.

Methodology

• The researchers conducted a randomised, observer-blinded, crossover study focusing on six horses, assessing the effects of four different treatments.
• These treatments, all administered intravenously, were: Saline and saline; 10 µg/kg detomidine and 7.5 µg/kg buprenorphine; 20 µg/kg detomidine and 7.5 µg/kg buprenorphine; and 20 µg/kg detomidine and 10 µg/kg buprenorphine.
• The degree of sedation was gauged subjectively and documented on a visual analogue scale.
• The significance of peak sedation and length of sedation were scrutinized utilizing a univariate general linear model with subsequent Tukey tests.

Findings

• When the same dose of buprenorphine (7.5 µg/kg) was administered, the sedative effect was enhanced by raising the dose of detomidine from 10 to 20 µg/kg.
• However, when 20 µg/kg detomidine was employed, elevating the dose of buprenorphine from 7.5 to 10 µg/kg had no notable influence on the achieved sedation level.

Conclusion

• This study’s results suggest that the sedative effect on horses increases when the dose of detomidine is increased from 10 to 20 µg/kg, provided the buprenorphine dose remains constant.
• Meanwhile, increasing the buprenorphine dose while maintaining a constant detomidine dose does not augment the sedative effect.
• Further research is required to pinpoint the precise interactions between these drugs and how they impact horses at varying doses.